Search Results

Lumiracoxib 250mg  | ≥99%

CSNpharm

Lumiracoxib is a COX2 selective inhibitor and a non-steroidal anti-inflammatory drug (NSAID), which inhibits COX2 with IC50 and Ki values of 0.14 μM and 0.06 μM and inhibits COX1 with Ki of 3 μM.

More Information Supplier Page

Lumiracoxib 50mg  | ≥99%

CSNpharm

Lumiracoxib is a COX2 selective inhibitor and a non-steroidal anti-inflammatory drug (NSAID), which inhibits COX2 with IC50 and Ki values of 0.14 μM and 0.06 μM and inhibits COX1 with Ki of 3 μM.

More Information Supplier Page

Lumiracoxib 100mg  | ≥99%

CSNpharm

Lumiracoxib is a COX2 selective inhibitor and a non-steroidal anti-inflammatory drug (NSAID), which inhibits COX2 with IC50 and Ki values of 0.14 μM and 0.06 μM and inhibits COX1 with Ki of 3 μM.

More Information Supplier Page

Lumiracoxib 10mg  | ≥99%

CSNpharm

Lumiracoxib is a COX2 selective inhibitor and a non-steroidal anti-inflammatory drug (NSAID), which inhibits COX2 with IC50 and Ki values of 0.14 μM and 0.06 μM and inhibits COX1 with Ki of 3 μM.

More Information Supplier Page

Nanofin 100mg  | ≥98%

CSNpharm

Nanofin is neuropathic blocker, with antihypertensive effect, used for mild to moderate hypertension.

More Information Supplier Page

2′,4′,6′-Trihydroxyacetophenone 100mg  | ≥99%

CSNpharm

2′,4′,6′-Trihydroxyacetophenone has antiobesity and hypolipidemic effects and may be partly mediated by delaying the intestinal absorption of dietary fat by inhibiting pancreatic lipase activity, it is a natural product isolated and purified from the barks of Albizia julibrissin.

More Information Supplier Page

2′,4′,6′-Trihydroxyacetophenone 25mg  | ≥99%

CSNpharm

2′,4′,6′-Trihydroxyacetophenone has antiobesity and hypolipidemic effects and may be partly mediated by delaying the intestinal absorption of dietary fat by inhibiting pancreatic lipase activity, it is a natural product isolated and purified from the barks of Albizia julibrissin.

More Information Supplier Page